![](/img/cover-not-exists.png)
Imatinib mesylate (Gleevec®) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity
Iman El Hajj Dib, Marlène Gallet, Romuald Mentaverri, Nicolas Sévenet, Michel Brazier, Said KamelVolume:
551
Year:
2006
Language:
english
Pages:
7
DOI:
10.1016/j.ejphar.2006.09.007
File:
PDF, 494 KB
english, 2006